APO Research

APO RESEARCH · REPORT

Biobased L-Valine

Selected research

Market Outlook & Growth Opportunities

Global Biobased L-Valine Market Outlook and Growth Opportunities 2026

Market perspective

The global Biobased L-Valine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biobased L-Valine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biobased L-Valine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biobased L-Valine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biobased L-Valine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biobased L-Valine market include Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd., Anhui Huaheng Biotechnology Co.,Ltd., Evonik Industries and CJ Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biobased L-Valine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biobased L-Valine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biobased L-Valine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biobased L-Valine market size, projected growth trends, production technologies, key applications, and end-use industries.

Biobased L-Valine Segment by Company

Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd.

Anhui Huaheng Biotechnology Co.,Ltd.

Evonik Industries

CJ Group

Biobased L-Valine Segment by Type

96%-98%

>98%

Biobased L-Valine Segment by Application

Pharmaceutical

Feed

Health Supplements

Others

Biobased L-Valine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biobased L-Valine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biobased L-Valine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biobased L-Valine significant trends, drivers, influence factors in global and regions.

6. To analyze Biobased L-Valine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobased L-Valine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobased L-Valine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobased L-Valine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biobased L-Valine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biobased L-Valine industry.

Chapter 3: Detailed analysis of Biobased L-Valine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biobased L-Valine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biobased L-Valine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biobased L-Valine Industry Trends Table 2. Biobased L-Valine Industry Drivers Table 3. Biobased L-Valine Industry Opportunities and Challenges Table 4. Biobased L-Valine Industry Restraints Table 5. Global Biobased L-Valine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biobased L-Valine Revenue Share by Company (2021-2026) Table 7. Global Biobased L-Valine Sales Volume by Company (t) & (2021-2026) Table 8. Global Biobased L-Valine Sales Volume Share by Company (2021-2026) Table 9. Global Biobased L-Valine Average Price (USD/t) of Company (2021-2026) Table 10. Global Biobased L-Valine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biobased L-Valine Key Company Manufacturing Base & Headquarters Table 12. Global Biobased L-Valine Company, Product Type & Application Table 13. Global Biobased L-Valine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biobased L-Valine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 96%-98% Table 18. Significant Companies of >98% Table 19. Global Biobased L-Valine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Biobased L-Valine Sales Volume by Type (2021-2026) & (t) Table 21. Global Biobased L-Valine Sales Volume by Type (2027-2032) & (t) Table 22. Global Biobased L-Valine Sales Volume Share by Type (2021-2026) Table 23. Global Biobased L-Valine Sales Volume Share by Type (2027-2032) Table 24. Global Biobased L-Valine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biobased L-Valine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Biobased L-Valine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Biobased L-Valine Sales Value Share by Type (2021-2026) Table 28. Global Biobased L-Valine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical Table 30. Significant Companies of Feed Table 31. Significant Companies of Health Supplements Table 32. Significant Companies of Others Table 33. Global Biobased L-Valine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Biobased L-Valine Sales Volume by Application (2021-2026) & (t) Table 35. Global Biobased L-Valine Sales Volume by Application (2027-2032) & (t) Table 36. Global Biobased L-Valine Sales Volume Share by Application (2021-2026) Table 37. Global Biobased L-Valine Sales Volume Share by Application (2027-2032) Table 38. Global Biobased L-Valine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Biobased L-Valine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Biobased L-Valine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Biobased L-Valine Sales Value Share by Application (2021-2026) Table 42. Global Biobased L-Valine Sales Value Share by Application (2027-2032) Table 43. Global Biobased L-Valine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Biobased L-Valine Sales by Region (2021-2026) & (t) Table 45. Global Biobased L-Valine Sales Market Share by Region (2021-2026) Table 46. Global Biobased L-Valine Sales by Region (2027-2032) & (t) Table 47. Global Biobased L-Valine Sales Market Share by Region (2027-2032) Table 48. Global Biobased L-Valine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Biobased L-Valine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Biobased L-Valine Sales Value Share by Region (2021-2026) Table 51. Global Biobased L-Valine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Biobased L-Valine Sales Value Share by Region (2027-2032) Table 53. Global Biobased L-Valine Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Biobased L-Valine Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Biobased L-Valine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Biobased L-Valine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Biobased L-Valine Sales by Country (2021-2026) & (t) Table 58. Global Biobased L-Valine Sales Market Share by Country (2021-2026) Table 59. Global Biobased L-Valine Sales by Country (2027-2032) & (t) Table 60. Global Biobased L-Valine Sales Market Share by Country (2027-2032) Table 61. Global Biobased L-Valine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Biobased L-Valine Sales Value Market Share by Country (2021-2026) Table 63. Global Biobased L-Valine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Biobased L-Valine Sales Value Market Share by Country (2027-2032) Table 65. Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Company Information Table 66. Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Business Overview Table 67. Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Biobased L-Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Biobased L-Valine Product Portfolio Table 69. Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Recent Development Table 70. Anhui Huaheng Biotechnology Co.,Ltd. Company Information Table 71. Anhui Huaheng Biotechnology Co.,Ltd. Business Overview Table 72. Anhui Huaheng Biotechnology Co.,Ltd. Biobased L-Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Anhui Huaheng Biotechnology Co.,Ltd. Biobased L-Valine Product Portfolio Table 74. Anhui Huaheng Biotechnology Co.,Ltd. Recent Development Table 75. Evonik Industries Company Information Table 76. Evonik Industries Business Overview Table 77. Evonik Industries Biobased L-Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Evonik Industries Biobased L-Valine Product Portfolio Table 79. Evonik Industries Recent Development Table 80. CJ Group Company Information Table 81. CJ Group Business Overview Table 82. CJ Group Biobased L-Valine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. CJ Group Biobased L-Valine Product Portfolio Table 84. CJ Group Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Biobased L-Valine Distributors List Table 88. Biobased L-Valine Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Biobased L-Valine Product Image Figure 2. Global Biobased L-Valine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biobased L-Valine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biobased L-Valine Sales (2021-2032) & (t) Figure 5. Global Biobased L-Valine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Biobased L-Valine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 96%-98% Image Figure 10. >98% Image Figure 11. Global Biobased L-Valine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Biobased L-Valine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Biobased L-Valine Sales Volume Share by Type (2021-2032) Figure 14. Global Biobased L-Valine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Biobased L-Valine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Biobased L-Valine Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical Image Figure 18. Feed Image Figure 19. Health Supplements Image Figure 20. Others Image Figure 21. Global Biobased L-Valine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Biobased L-Valine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Biobased L-Valine Sales Volume Share by Application (2021-2032) Figure 24. Global Biobased L-Valine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Biobased L-Valine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Biobased L-Valine Sales Value Share by Application (2021-2032) Figure 27. Global Biobased L-Valine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Biobased L-Valine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Biobased L-Valine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Biobased L-Valine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Biobased L-Valine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Biobased L-Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Biobased L-Valine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Biobased L-Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Biobased L-Valine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Biobased L-Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Biobased L-Valine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Biobased L-Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Biobased L-Valine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Biobased L-Valine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Biobased L-Valine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Biobased L-Valine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Biobased L-Valine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Biobased L-Valine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Biobased L-Valine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 96%-98%
  • >98%
Applications
  • Pharmaceutical
  • Feed
  • Health Supplements
  • Others
Companies covered
  • Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd.
  • Anhui Huaheng Biotechnology Co.,Ltd.
  • Evonik Industries
  • CJ Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biobased L-Valine Sales Value (2021-2032)
  4. 1.2.2 Global Biobased L-Valine Sales Volume (2021-2032)
  5. 1.2.3 Global Biobased L-Valine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biobased L-Valine Market Dynamics
  1. 2.1 Biobased L-Valine Industry Trends
  2. 2.2 Biobased L-Valine Industry Drivers
  3. 2.3 Biobased L-Valine Industry Opportunities and Challenges
  4. 2.4 Biobased L-Valine Industry Restraints
3 Biobased L-Valine Market by Company
  1. 3.1 Global Biobased L-Valine Company Revenue Ranking in 2025
  2. 3.2 Global Biobased L-Valine Revenue by Company (2021-2026)
  3. 3.3 Global Biobased L-Valine Sales Volume by Company (2021-2026)
  4. 3.4 Global Biobased L-Valine Average Price by Company (2021-2026)
  5. 3.5 Global Biobased L-Valine Company Ranking (2024-2026)
  6. 3.6 Global Biobased L-Valine Company Manufacturing Base and Headquarters
  7. 3.7 Global Biobased L-Valine Company Product Type and Application
  8. 3.8 Global Biobased L-Valine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biobased L-Valine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biobased L-Valine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biobased L-Valine Market by Type
  1. 4.1 Biobased L-Valine Type Introduction
  2. 4.1.1 96%-98%
  3. 4.1.2 >98%
  4. 4.2 Global Biobased L-Valine Sales Volume by Type
  5. 4.2.1 Global Biobased L-Valine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biobased L-Valine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Biobased L-Valine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Biobased L-Valine Sales Value by Type
  9. 4.3.1 Global Biobased L-Valine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Biobased L-Valine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Biobased L-Valine Sales Value Share by Type (2021-2032)
5 Biobased L-Valine Market by Application
  1. 5.1 Biobased L-Valine Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Feed
  4. 5.1.3 Health Supplements
  5. 5.1.4 Others
  6. 5.2 Global Biobased L-Valine Sales Volume by Application
  7. 5.2.1 Global Biobased L-Valine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Biobased L-Valine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Biobased L-Valine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Biobased L-Valine Sales Value by Application
  11. 5.3.1 Global Biobased L-Valine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Biobased L-Valine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Biobased L-Valine Sales Value Share by Application (2021-2032)
6 Biobased L-Valine Regional Sales and Value Analysis
  1. 6.1 Global Biobased L-Valine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biobased L-Valine Sales by Region (2021-2032)
  3. 6.2.1 Global Biobased L-Valine Sales by Region: 2021-2026
  4. 6.2.2 Global Biobased L-Valine Sales by Region (2027-2032)
  5. 6.3 Global Biobased L-Valine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biobased L-Valine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biobased L-Valine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biobased L-Valine Sales Value by Region (2027-2032)
  9. 6.5 Global Biobased L-Valine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biobased L-Valine Sales Value (2021-2032)
  12. 6.6.2 North America Biobased L-Valine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biobased L-Valine Sales Value (2021-2032)
  15. 6.7.2 Europe Biobased L-Valine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biobased L-Valine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biobased L-Valine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biobased L-Valine Sales Value (2021-2032)
  21. 6.9.2 South America Biobased L-Valine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biobased L-Valine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biobased L-Valine Sales Value Share by Country, 2025 VS 2032
7 Biobased L-Valine Country-level Sales and Value Analysis
  1. 7.1 Global Biobased L-Valine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biobased L-Valine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biobased L-Valine Sales by Country (2021-2032)
  4. 7.3.1 Global Biobased L-Valine Sales by Country (2021-2026)
  5. 7.3.2 Global Biobased L-Valine Sales by Country (2027-2032)
  6. 7.4 Global Biobased L-Valine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biobased L-Valine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biobased L-Valine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biobased L-Valine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biobased L-Valine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biobased L-Valine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biobased L-Valine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biobased L-Valine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biobased L-Valine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biobased L-Valine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biobased L-Valine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biobased L-Valine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biobased L-Valine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biobased L-Valine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biobased L-Valine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biobased L-Valine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biobased L-Valine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biobased L-Valine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biobased L-Valine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biobased L-Valine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biobased L-Valine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biobased L-Valine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biobased L-Valine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biobased L-Valine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biobased L-Valine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biobased L-Valine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biobased L-Valine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biobased L-Valine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biobased L-Valine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biobased L-Valine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biobased L-Valine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biobased L-Valine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biobased L-Valine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd.
  2. 8.1.1 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Company Information
  3. 8.1.2 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Business Overview
  4. 8.1.3 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Biobased L-Valine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Biobased L-Valine Product Portfolio
  6. 8.1.5 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Recent Developments
  7. 8.2 Anhui Huaheng Biotechnology Co.,Ltd.
  8. 8.2.1 Anhui Huaheng Biotechnology Co.,Ltd. Company Information
  9. 8.2.2 Anhui Huaheng Biotechnology Co.,Ltd. Business Overview
  10. 8.2.3 Anhui Huaheng Biotechnology Co.,Ltd. Biobased L-Valine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Anhui Huaheng Biotechnology Co.,Ltd. Biobased L-Valine Product Portfolio
  12. 8.2.5 Anhui Huaheng Biotechnology Co.,Ltd. Recent Developments
  13. 8.3 Evonik Industries
  14. 8.3.1 Evonik Industries Company Information
  15. 8.3.2 Evonik Industries Business Overview
  16. 8.3.3 Evonik Industries Biobased L-Valine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Industries Biobased L-Valine Product Portfolio
  18. 8.3.5 Evonik Industries Recent Developments
  19. 8.4 CJ Group
  20. 8.4.1 CJ Group Company Information
  21. 8.4.2 CJ Group Business Overview
  22. 8.4.3 CJ Group Biobased L-Valine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CJ Group Biobased L-Valine Product Portfolio
  24. 8.4.5 CJ Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biobased L-Valine Value Chain Analysis
  2. 9.1.1 Biobased L-Valine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biobased L-Valine Sales Mode & Process
  6. 9.2 Biobased L-Valine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biobased L-Valine Distributors
  9. 9.2.3 Biobased L-Valine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research